Kenvue Inc. (KVUE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kenvue Inc. (KVUE) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($294.00 Million) by net assets ($10.63 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kenvue Inc. (KVUE) defensive interval to measure how many days the company can operate on defensive assets alone.
Kenvue Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Kenvue Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kenvue Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kenvue Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Telefonaktiebolaget LM Ericsson (publ)
F:ERCA
|
0.077x |
|
Las Vegas Sands Corp
NYSE:LVS
|
0.623x |
|
Shinhan Financial Group
KO:055550
|
0.205x |
|
SANDVIK AB SP.ADR
F:SVK
|
0.046x |
|
Accelink Technologies Co Ltd
SHE:002281
|
0.114x |
|
Orix Corp Ads
F:OIXA
|
0.068x |
|
Koninklijke Ahold Delhaize NV
AS:AD
|
0.051x |
|
Kinross Gold Corp
TO:K
|
0.124x |
Annual Cash Flow Conversion Efficiency for Kenvue Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Kenvue Inc. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see Kenvue Inc. (KVUE) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $9.67 Billion | $1.77 Billion | 0.183x | -35.25% |
| 2023-12-31 | $11.21 Billion | $3.17 Billion | 0.283x | +123.49% |
| 2022-12-31 | $19.97 Billion | $2.52 Billion | 0.126x | +672.23% |
| 2021-12-31 | $20.40 Billion | $334.00 Million | 0.016x | -91.15% |
| 2020-12-31 | $18.36 Billion | $3.40 Billion | 0.185x | -- |
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, … Read more